GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medipharco Pharmaceutical JSC (HSTC:MTP) » Definitions » Interest Expense

Medipharco Pharmaceutical JSC (HSTC:MTP) Interest Expense : ₫ Mil (TTM As of . 20)


View and export this data going back to 2010. Start your Free Trial

What is Medipharco Pharmaceutical JSC Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medipharco Pharmaceutical JSC's interest expense for the six months ended in . 20 was ₫ 0.00 Mil. Medipharco Pharmaceutical JSC does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medipharco Pharmaceutical JSC's Operating Income for the six months ended in . 20 was ₫ 0.00 Mil. Medipharco Pharmaceutical JSC's Interest Expense for the six months ended in . 20 was ₫ 0.00 Mil. Medipharco Pharmaceutical JSC did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Medipharco Pharmaceutical JSC Interest Expense Historical Data

The historical data trend for Medipharco Pharmaceutical JSC's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipharco Pharmaceutical JSC Interest Expense Chart

Medipharco Pharmaceutical JSC Annual Data
Trend
Interest Expense

Medipharco Pharmaceutical JSC Semi-Annual Data
Interest Expense

Medipharco Pharmaceutical JSC Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Medipharco Pharmaceutical JSC  (HSTC:MTP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medipharco Pharmaceutical JSC's Interest Expense for the six months ended in . 20 was ₫0.00 Mil. Its Operating Income for the six months ended in . 20 was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was ₫0.00 Mil.

Medipharco Pharmaceutical JSC's Interest Coverage for the quarter that ended in . 20 is calculated as

Medipharco Pharmaceutical JSC had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Medipharco Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
08 Nguyen Truong to Street, Phuoc Vinh Ward, Thien Hue Province, Hue, VNM
Medipharco Pharmaceutical JSC is engaged in manufacturing, trading, and import-export medicines, medical equipment, and supplies, cosmetic products, sanitary products, biological products, essential oils, aromatherapy. Its products consist of Betamethason, Gentameson, Neutasol, Mediclovir, Rhumenol flu 500, and Clotrimazol among others.

Medipharco Pharmaceutical JSC Headlines

No Headlines